HLA-G expression has also been shown to be associated with a shortened time to recurrence, DFS and OS in several other malignancies such as gastric cancer, breast cancer, lung cancer and malignant melanoma [30–33]. This evidence concerns the gene HLA-G and lung carcinoma.